Does basal luteinizing hormone help predict the fate of in vitro fertilization? [0.03%]
基础黄体生成素能预测体外受精的结局吗？
Saloni Bansal,Neeta Singh,Prerna Gupta et al.
Saloni Bansal et al.
Objective: Evaluate the role of baseline serum luteinizing hormone (LH) in predicting the success of in-vitro fertilization (IVF) in terms of clinical pregnancy and live birth rate. ...
Male cytogenetic evaluation prior to assisted reproduction procedures performed in Mar del Plata, Argentina [0.03%]
阿根廷马德普拉塔辅助生育前男性的染色体检查
María N Poli,Lucía A López Miranda,Eduardo Daniel Gil et al.
María N Poli et al.
Objective: This paper aimed to estimate the frequency of occurrence and the types of chromosomal abnormalities found in 141 infertile men with abnormal semen parameters. ...
Comparing stimulation requirements and final outcome between early follicular and mid luteal pituitary suppression in the long gonadotropin releasing hormone agonist protocol [0.03%]
长效促性腺激素释放激素激动剂方案中卵泡早期和黄体中期垂体抑制的刺激需求及最终结局的比较
Abdulmagid Sarhan,Mervat Harira,Sherine Elshazly et al.
Abdulmagid Sarhan et al.
Objective: To compare stimulation requirements and ICSI outcome when agonist treatment is started in the early follicular phase or in mid luteal phase of the cycle. ...
Randomized Controlled Trial
JBRA assisted reproduction. 2016 May 1;20(2):59-61. DOI:10.5935/1518-0557.20160014 2016
Assisted reproductive techniques in Latin America: The Latin American Registry, 2013 [0.03%]
拉丁美洲的辅助生殖技术：2013年拉丁美洲注册数据
Fernando Zegers-Hochschild,Juan Enrique Schwarze,Javier A Crosby et al.
Fernando Zegers-Hochschild et al.
Multinational data on assisted reproduction techniques undertaken in 2013 were collected from 158 institutions in 15 Latin American countries. Individualized cycle-based data included 57,456 initiated cycles. Treatments included autologous ...
Total motile sperm count: a better way to rate the severity of male factor infertility? [0.03%]
总体活动精子计数：更好的男性不孕症严重程度评估方法？
Edson Borges Jr
Edson Borges Jr
Maria Teresa Urbina
Maria Teresa Urbina
Live Births after Fertility-saving Surgery in Ovarian Borderline Tumor and Oocyte Donation: Case Report [0.03%]
保留生育功能的卵巢交界性肿瘤手术后活产及卵子捐赠案例报告
Maria do Carmo Borges de Souza,Roberto de Azevedo Antunes,Marcelo Marinho de Souza et al.
Maria do Carmo Borges de Souza et al.
A left borderline serous ovarian tumor stage I (FIGO) was discovered and treated in a 26-year-old black nulliparous woman, by conservative approach (laparotomy, salpingo- oophorectomy). In a six months interval she had a 7.5 x 7.1 x 5.7cm m...
Improvement in Serum Anti-Müllerian Hormone Levels in Infertile Patients after Hyperbaric Oxygen (preliminary results) [0.03%]
高压氧治疗改善不孕症患者血清抗穆勒管激素水平(初步报告)
Jesus Fernando Gallardo Pineda,Carlos Gerardo Salazar López Ortiz,Gonzalo de Jesus Siu Moguel et al.
Jesus Fernando Gallardo Pineda et al.
Objective: To assess whether hyperbaric oxygen sessions elevate serum levels of anti-Müllerian hormone (AMH) in patients diagnosed with infertility with serum levels of less than or equal to 1 ng/dl AMH. ...